University Kantonsspital Baselland
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leibundgut, Gregor
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Recruiting
4
3010
Europe
P2Y12 inhibitor, Aspirin, DOAC
Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor
09/26
12/26
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
NCT03587922: FANTOM Post Market Clinical Trial

Recruiting
N/A
1500
Europe
Fantom
REVA Medical, Inc.
Coronary Artery Disease
05/25
05/25
DISCO COMPLEX, NCT05490238: DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention

Recruiting
N/A
708
Europe
Complex PCI with Ultimaster family drug-eluting stent (Terumo Corp., Japan)
IGLESIAS Juan Fernando, University of Bern
Vascular Access Site Occlusion
05/25
05/26
NCT06055920: The PEERLESS II Study

Recruiting
N/A
1200
Europe, Canada, US
FlowTriever System, Anticoagulation Agents
Inari Medical
Pulmonary Embolism
07/26
07/26
NAGOMI COMPLEX, NCT05705973: Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

Recruiting
N/A
3000
Europe
Ultimaster Nagomi™
Terumo Europe N.V.
Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
09/26
09/27
CARDSUP, NCT04117230: - SWISS Circulatory Support Registry

Recruiting
N/A
1500
Europe
Insel Gruppe AG, University Hospital Bern
Cardiogenic Shock
08/34
08/34

Download Options